scholarly article | Q13442814 |
P356 | DOI | 10.1592/PHCO.30.9.928 |
P698 | PubMed publication ID | 20795848 |
P2093 | author name string | Patrick R Finley | |
Ellen Haller | |||
Winnie Yeung | |||
Cheryl K Hirata | |||
Rosalyn C Ng | |||
P2860 | cites work | Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry | Q28281056 |
Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study | Q30907762 | ||
The effectiveness of exercise in the management of post-natal depression: systematic review and meta-analysis | Q33397987 | ||
Effects of gonadal steroids in women with a history of postpartum depression | Q33903674 | ||
Onset and persistence of postpartum depression in an inner-city maternal health clinic system. | Q34100217 | ||
The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcomes | Q34239131 | ||
The safety of newer antidepressants in pregnancy and breastfeeding | Q34390866 | ||
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine | Q34775057 | ||
Gender differences in depression and response to antidepressant treatment | Q35561518 | ||
Mood disturbance in the early puerperium: a review | Q35582933 | ||
Prevalence of suicidality during pregnancy and the postpartum | Q36121838 | ||
Prevention and treatment of postnatal depression | Q36817068 | ||
Analysis of positive Edinburgh depression scale referrals to a consultation liaison psychiatry service in a two-year period | Q36834324 | ||
Antidepressant use in the postpartum period: practical considerations | Q36922809 | ||
A reproductive subtype of depression: conceptualizing models and moving toward etiology | Q37089316 | ||
Management of postnatal depression | Q37238659 | ||
Transdermal estradiol for postpartum depression: a promising treatment option | Q37435819 | ||
Essential fatty acids in pregnancy and early human development | Q40940104 | ||
Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study | Q41106513 | ||
Women's views of antidepressants in the treatment of postnatal depression. | Q42648086 | ||
Prevalence, onset and comorbidity of postpartum anxiety and depressive disorders | Q43691637 | ||
Fluvoxamine for postpartum depression | Q43752251 | ||
Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis | Q43901012 | ||
Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women | Q43941619 | ||
Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing | Q44442042 | ||
Role functioning and symptom remission in women with postpartum depression after antidepressant treatment | Q44699793 | ||
Omega-3 polyunsaturated fatty acids for postpartum depression | Q44787434 | ||
Alterations in platelet serotonin transporter binding in women with postpartum onset major depression | Q45068225 | ||
Bupropion SR for the treatment of postpartum depression: a pilot study | Q46427315 | ||
Nefazodone for the treatment of postpartum depression | Q46469694 | ||
Sex differences in antidepressant response in recent antidepressant clinical trials | Q46596828 | ||
Efficacy of the kampo medicine xiong-gui-tiao-xue-yin (kyuki-chouketsu-in), a traditional herbal medicine, in the treatment of maternity blues syndrome in the postpartum period | Q47279486 | ||
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action | Q48153911 | ||
Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression | Q48336624 | ||
Health-related quality of life in postpartum depressed women | Q48529177 | ||
Psychopathology and marital satisfaction: the importance of evaluating both partners. | Q50989782 | ||
Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. | Q51113577 | ||
Patient choice of treatment for postpartum depression: a pilot study. | Q51913324 | ||
Postpartum depression treatment rates for at-risk women. | Q51919290 | ||
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. | Q51922714 | ||
Effects of Maternal Depression on Cognitive Development of Children Over the First 7 Years of Life | Q56637142 | ||
Obsessive-compulsive symptoms in pregnancy and the puerperium: | Q56804378 | ||
A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones | Q58053410 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | postpartum depression | Q935129 |
pharmacology | Q128406 | ||
systematic review | Q1504425 | ||
P304 | page(s) | 928-941 | |
P577 | publication date | 2010-09-01 | |
P1433 | published in | Pharmacotherapy | Q7180800 |
P1476 | title | Pharmacologic treatment for postpartum depression: a systematic review | |
P478 | volume | 30 |
Q37362209 | A pilot study evaluating genetic and environmental factors for postpartum depression |
Q37688604 | Are antidepressants effective in the treatment of postpartum depression? A systematic review |
Q28071504 | Chinese Herbal Medicine for Postpartum Depression: A Systematic Review of Randomized Controlled Trials |
Q46780905 | Detection and treatment rates for perinatal depression in a state Medicaid population |
Q48358069 | Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling |
Q36455917 | Efficacy of light therapy for perinatal depression: a review |
Q35092485 | Enhanced responsiveness to selective serotonin reuptake inhibitors during lactation |
Q43447962 | Group treatment for depression in mothers of young children compared to standard individual therapy |
Q34143957 | How generalized CNS arousal strengthens sexual arousal (and vice versa). |
Q48514039 | Korean Medication Algorithm for Depressive Disorders 2017: Third Revision. |
Q27024923 | Perinatal depression: an update and overview |
Q36639113 | Postpartum depression: psychoneuroimmunological underpinnings and treatment |
Q34426059 | Trajectories of depressive symptoms over 2 years postpartum among overweight or obese women |
Search more.